Feb 3 (Reuters) - Serina Therapeutics Inc SER.A:
SERINA THERAPEUTICS RECEIVES SECOND $5 MILLION TRANCHE TO STRENGTHEN CASH POSITION AHEAD OF PHASE 1 CLINICAL TRIAL IN ADVANCED PARKINSON'S DISEASE PATIENTS
SERINA THERAPEUTICS INC - FUNDING TO ADVANCE SER-252 INTO PHASE 1 TRIAL IN H2 2025
Source text: ID:nGNX4tg92z
Further company coverage: SER.A
((reuters.briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.